JAZZ (STOCKS)
Jazz Pharmaceuticals, Inc.
$166.240000
+0.610000 (+0.37%)
Prev close: $165.630000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Renée D. Galá
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $10,108.31M
- Employees
- 2,800
- P/E (TTM)
- -27.29
- P/B (TTM)
- 2.54
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $4.16B |
| Benefits Costs and Expenses | $4.86B |
| Costs And Expenses | $4.65B |
| Operating Expenses | $4.65B |
| Selling, General, and Administrative Expenses | $1.77B |
| Other Operating Expenses | $2.88B |
| Operating Income/Loss | -$494.01M |
| Income/Loss Before Equity Method Investments | -$703.11M |
| Income/Loss From Continuing Operations After Tax | -$368.42M |
| Income/Loss From Continuing Operations Before Tax | -$703.11M |
| Income/Loss From Equity Method Investments | -$691.00K |
| Income Tax Expense/Benefit | -$335.32M |
| Income Tax Expense/Benefit, Deferred | -$384.02M |
| Net Income/Loss | -$368.48M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$368.48M |
| Net Income/Loss Available To Common Stockholders, Basic | -$368.48M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$5.99 |
| Diluted Earnings Per Share | -$6.16 |
| Basic Average Shares | 182,432,000 |
| Diluted Average Shares | 182,275,000 |
| Assets | $11.36B |
| Current Assets | $3.76B |
| Inventory | $483.11M |
| Prepaid Expenses | $146.89M |
| Other Current Assets | $3.13B |
| Noncurrent Assets | $7.60B |
| Intangible Assets | $4.57B |
| Other Non-current Assets | $3.03B |
| Liabilities | $7.40B |
| Current Liabilities | $2.27B |
| Accounts Payable | $152.23M |
| Other Current Liabilities | $2.12B |
| Noncurrent Liabilities | $5.12B |
| Long-term Debt | $5.36B |
| Equity | $3.96B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $3.96B |
| Liabilities And Equity | $11.36B |
| Net Cash Flow From Operating Activities | $1.39B |
| Net Cash Flow From Operating Activities, Continuing | $1.39B |
| Net Cash Flow From Investing Activities | -$1.33B |
| Net Cash Flow From Investing Activities, Continuing | -$1.33B |
| Net Cash Flow From Financing Activities | -$957.10M |
| Net Cash Flow From Financing Activities, Continuing | -$957.10M |
| Exchange Gains/Losses | $4.23M |
| Net Cash Flow | -$892.07M |
| Net Cash Flow, Continuing | -$896.30M |
| Comprehensive Income/Loss | -$796.88M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$334.99M |
| Other Comprehensive Income/Loss | $14.13M |
| Other Comprehensive Income/Loss Attributable To Parent | $33.50M |